<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-ectd-v4-sample-submission-pathway-technical-filing-errors</loc>
    <lastmod>2026-10-29T23:04:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Opens eCTD v4.0 Sample Submission Pathway to Reduce Technical Filing Errors</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d6d4b767-4fce-4920-8ceb-f4382d91cc7c/a5abf54c-f4ee-4fb0-9545-2c733d8f00cb.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-draft-guidance-drug-delivery-performance-characteristics-combination-products</loc>
    <lastmod>2026-10-29T23:04:55+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Issues Draft Guidance on Essential Drug Delivery Performance Characteristics for Combination Products</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d6d4b767-4fce-4920-8ceb-f4382d91cc7c/0dbb0922-2762-4a63-bb23-9516dfb1984f.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-ectd-v4-forward-compatibility-october-2026</loc>
    <lastmod>2026-10-29T23:06:59+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Activates eCTD v4.0 Forward Compatibility for NDAs, ANDAs, BLAs, and INDs</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/d6d4b767-4fce-4920-8ceb-f4382d91cc7c/f2bcf64e-7d1c-418e-8790-65b9c7afaea7.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/insmed-fda-priority-review-arikayce-snda-japan-brinsupri-ncfb-approval</loc>
    <lastmod>2026-10-29T23:08:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>Insmed Gains FDA Priority Review for ARIKAYCE sNDA</news:title>
      <news:keywords>Insmed</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/3c76b4f6-6e83-4453-b20a-5f1c49428130/d7fd3775-091d-4b69-b585-f75cf13e060a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-confirms-rx7-articulaciones-hidden-diclofenac-dexamethasone</loc>
    <lastmod>2026-10-29T22:58:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Confirms RX7 Articulaciones Contains Undeclared Diclofenac and Dexamethasone</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/53f0ae70-8371-4518-ac99-64047f7d6795/79bd1e8b-f9c6-4673-864a-1510efb7e33d.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-confirms-ort-flx-undeclared-diclofenac-dexamethasone-methocarbamol</loc>
    <lastmod>2026-10-29T22:57:06+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Confirms Ort-Flx Contains Undeclared Diclofenac, Dexamethasone, and Methocarbamol</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/53f0ae70-8371-4518-ac99-64047f7d6795/932503d6-15a1-42fd-ab17-599b3ac6d228.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/azora-therapeutics-appoints-executive-team-at177-phase-1-ulcerative-colitis-2027</loc>
    <lastmod>2026-10-29T23:01:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>Azora Therapeutics Appoints New Executive Team to Advance AT177</news:title>
      <news:keywords>Azora</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/https://www.globenewswire.com/newsroom/ti?nf=OTg1NTUxMiM3OTIyNzU1IzUwMDE2MzYxNQ==</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-biosimilar-approval-tracker-2024-2026</loc>
    <lastmod>2026-10-29T22:56:07+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T00:00:00+05:30</news:publication_date>
      <news:title>FDA Biosimilar Approval Tracker Shows 30-Plus Products Cleared Since Mid-2024</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/229aead9-9f5e-4dd9-a129-4cf27dbddb6e/bff16c97-25f1-4eba-9bd1-42ca03548760.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-refreshes-drug-approvals-databases-portal-regulatory-tools</loc>
    <lastmod>2026-10-29T12:12:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Refreshes Drug Approvals Portal With 20+ Regulatory Tools</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-drug-approvals-databases-portal-regulatory-tools-202620261029121114.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-21st-century-cures-act-eua-gmp-waiver-mcm-manufacturers</loc>
    <lastmod>2026-10-29T12:02:52+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Cures Act Expands EUA Powers and MCM Review Vouchers</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-21st-century-cures-act-eua-gmp-waivers-mcm-review-vouchers-202620261029120153.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-tropical-disease-priority-review-voucher-guidance-fdaaa-section-524</loc>
    <lastmod>2026-10-29T11:57:36+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Reissues Tropical Disease Priority Review Voucher Guidance</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-tropical-disease-priority-review-voucher-guidance-section-524-202620261029115726.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/benitec-biopharma-bb-301-phase-1b-2a-opmd-interim-results</loc>
    <lastmod>2026-10-29T11:54:04+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>Benitec Reports 100% Response Rate in BB-301 OPMD Trial</news:title>
      <news:keywords>Benitec</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/benitec-bb-301-phase-1b-2a-opmd-interim-results-202620261029115354.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/teva-acquires-bioxcel-assets-at-home-acute-agitation-treatment</loc>
    <lastmod>2026-10-29T11:48:23+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>Teva Acquires BioXcel's BXCL501 Assets for At-Home Treatment</news:title>
      <news:keywords>Teva</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/teva-bioxcel-bxcl501-at-home-acute-agitation-treatment-202620261029114727.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/sudeep-pharma-fda-approval-nandesari-gujarat-facility-h2-fy27</loc>
    <lastmod>2026-10-29T11:37:01+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>Sudeep Pharma Gains FDA Approval for Nandesari Gujarat Facility</news:title>
      <news:keywords>Sudeep</news:keywords>
    </news:news>
    
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/jubilant-biosys-appoints-dr-sk-dhakshinamoorthy-senior-vp-strategy-value-creation</loc>
    <lastmod>2026-10-29T11:32:40+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>Jubilant Biosys Appoints Dr. SK Dhakshinamoorthy as Senior VP</news:title>
      <news:keywords>Jubilant</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/jubilant-biosys-sk-dhakshinamoorthy-senior-vp-strategy-value-creation-202620261029113231.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-renews-peripheral-cns-drugs-advisory-committee-charter</loc>
    <lastmod>2026-10-29T11:16:59+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Renews Peripheral and CNS Drugs Advisory Committee</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-peripheral-cns-drugs-advisory-committee-charter-renewal-202620261029111638.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-compliance-policy-guides-manual-enforcement-priorities-drug-plant-inspections</loc>
    <lastmod>2026-10-29T11:09:18+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>FDA Compliance Policy Guides Shape Drug Plant Inspections</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-compliance-policy-guides-drug-plant-inspection-enforcement-priorities-202620261029110800.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/amgen-fda-opdp-warning-letter-vectibix-promotional-video-2026</loc>
    <lastmod>2026-10-29T10:59:15+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00+05:30</news:publication_date>
      <news:title>Amgen Receives FDA Warning Letter Over Vectibix Video</news:title>
      <news:keywords>Amgen</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/amgen-fda-opdp-warning-letter-vectibix-promotional-video-202620261029105846.webp</image:loc>
    </image:image>
  </url>
</urlset>